Docoh
Loading...

GSTC GlobeStar Therapeutics

176 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
GSTC GlobeStar Therapeutics Corp
12 Oct 21
Regulation FD Disclosure
8:27am
8-K
GSTC GlobeStar Therapeutics Corp
4 Oct 21
Regulation FD Disclosure
8:48am
8-K
GSTC GlobeStar Therapeutics Corp
20 Sep 21
Multiple Sclerosis Drug Development Information September 2021
8:16am
10-Q
2021 Q3
GSTC GlobeStar Therapeutics Corp
23 Aug 21
Quarterly report
12:44pm
NT 10-Q
GSTC GlobeStar Therapeutics Corp
16 Aug 21
Notice of late quarterly filing
4:33pm
10-Q
2021 Q2
GSTC GlobeStar Therapeutics Corp
21 May 21
Quarterly report
3:33pm
NT 10-Q
GSTC GlobeStar Therapeutics Corp
17 May 21
Notice of late quarterly filing
11:37am
8-K
GSTC GlobeStar Therapeutics Corp
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
GSTC GlobeStar Therapeutics Corp
5 May 21
Regulation FD Disclosure
4:17pm
3
William J Farley
23 Apr 21
AngioSoma / William J Farley ownership change
4:14pm
8-K
GSTC GlobeStar Therapeutics Corp
16 Apr 21
AngioSoma, Inc. Is Pleased to Welcome William Farley to Its Board of Directors
4:20pm
8-K
GSTC GlobeStar Therapeutics Corp
5 Mar 21
Departure of Directors or Certain Officers
8:49am
8-K
GSTC GlobeStar Therapeutics Corp
25 Feb 21
Angiosoma and its Subsidiary Somaceuticals Announce Amended and Restated Execution of Global License for Multiple Sclerosis Patent
5:30pm
10-Q
2021 Q1
GSTC GlobeStar Therapeutics Corp
28 Jan 21
Quarterly report
2:17pm
8-K
GSTC GlobeStar Therapeutics Corp
22 Dec 20
Regulation FD Disclosure
5:14pm
8-K
GSTC GlobeStar Therapeutics Corp
8 Dec 20
SomaCeuticals Moving Forward With Treatment of Multiple Sclerosis
7:00pm
10-K
2020 FY
GSTC GlobeStar Therapeutics Corp
3 Dec 20
Annual report
4:46pm
3
GSTC GlobeStar Therapeutics Corp
13 Oct 20
AngioSoma / JAMES C KATZAROFF ownership change
2:17pm
4/A
GSTC GlobeStar Therapeutics Corp
25 Aug 20
AngioSoma / Alex K Blankenship ownership change
11:03am
8-K
GSTC GlobeStar Therapeutics Corp
24 Aug 20
SomaCeuticals Acquires License for Treatment of Multiple Sclerosis
5:01pm